Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Trimetrexate MeSH Descriptor Data 2026


MeSH Heading
Trimetrexate
Tree Number(s)
D03.633.100.786.925
Unique ID
D016597
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016597
Scope Note
A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.
Entry Term(s)
CI-898
JB-11
NSC-249008
NSC-328564
Trimetrexate Hydrate
Trimetrexate Monohydrate, Monoacetate
Pharm Action
Antifungal Agents
Antimetabolites, Antineoplastic
Folic Acid Antagonists
Registry Numbers
UPN4ITI8T4
117381-09-6
117381-10-9
0
Related Numbers
117381-09-6
117381-10-9
52128-35-5
CAS Type 1 Name
2,4-Quinazolinediamine, 5-methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-
Previous Indexing
Antineoplastic Agents (1966-1991)
Folic Acid Antagonists (1966-1991)
Quinazolines (1966-1991)
Public MeSH Note
92; TRIMETREXATE was indexed under QUINAZOLINES 1979-91
Online Note
use TRIMETREXATE (NM) to search TRIMETREXATE 1980-91
History Note
92; was TRIMETREXATE (NM) 1979-91
Date Introduced
1992/01/01
Last Updated
2017/05/24
Trimetrexate Preferred
Trimetrexate Monohydrate, Monoacetate Narrower
Trimetrexate Hydrate Narrower
CI-898 Narrower
JB-11 Narrower
NSC-328564 Narrower
NSC-249008 Narrower
page delivered in 0.149s